dc.contributorVelandia Martinez, Ariana K
dc.contributorOrtiz Salas, Paola Andrea
dc.contributorGaona Barbosa, Iván Augusto
dc.creatorOrtega Sánchez, Mónica Andrea
dc.creatorVásquez García, Manuel Sebastián
dc.date.accessioned2020-10-22T00:47:28Z
dc.date.accessioned2022-09-22T14:44:38Z
dc.date.available2020-10-22T00:47:28Z
dc.date.available2022-09-22T14:44:38Z
dc.date.created2020-10-22T00:47:28Z
dc.identifierhttps://repository.urosario.edu.co/handle/10336/30440
dc.identifierhttps://doi.org/10.48713/10336_30440
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3441693
dc.description.abstractStatus epilepticus (SE) is a prevalent neurological emergency, with consequences both primary in the central nervous system and secondary from a systemic point of view, with important aftermaths in terms of morbidity and mortality. The detection of risk factors involved in its appearance, perpetuation and complications, is needed in order to mitigate the damage produced along each stage of SE. Methodology: A descriptive observational case-series trial was conducted in patients over 18 years with status epilepticus treated in a high complexity university hospital in Bogotá, Colombia, between 2016-2018, describing clinical, paraclinical features and STESS (Status Epilepticus Severity Score) score. The data were analyzed using the SPSS platform (IBM Statistics). Results: A total sample of 83 patients was obtained for the final analysis. 63.9% were men, and the median age was 59 years. 85.5% of the patients had convulsive SE and in 50.6% of the cases they required ICU management. The etiology of SE was undetermined in 38.6%, followed by antiepileptic drug deprivation (20.5%). In general, 22.9% had complications, 47.4% related to the ICU stay, followed by associated with pharmacological treatment (26.3%). Mortality secondary to SE was 5.3%, while overall mortality was recorded at 16.9%. The mean hospital stay was 25 days in the group of patients with complications vs. 9 days in those without. The STESS score was found in an unfavorable range (≥3) in 44.5% and 29.7% in the group of patients with complications. Conclusions: Demographic, clinical, and paraclinical features, with focus on comorbidities, electroencephalographic patterns, and STESS score, could be related to the presence of complications and mortality in colombian patients with status epilepticus.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Neurología
dc.publisherFacultad de Medicina
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceTrinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515–23
dc.sourceChin RFM, Neville BGR, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11(12):800–10
dc.sourceBetjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol [Internet]. 2015;14(6):615–24. Available from: http://dx.doi.org/10.1016/S1474-4422(15)00042-3
dc.sourceHocker S. Systemic complications of status epilepticus - An update. Epilepsy Behav [Internet]. 2015;49:83–7. Available from: http://dx.doi.org/10.1016/j.yebeh.2015.04.024
dc.sourceManno EM, Pfeifer EA, Cascino GD, Noe KH, Wijdicks EFM. Cardiac pathology in status epilepticus. Ann Neurol. 2005;58(6):954–7
dc.sourceCooper AD, Britton JW, Rabinstein AA. Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol [Internet]. 2009;66(12):1505–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20008655
dc.sourceLegriel S, Azoulay E, Resche-Rigon M, Lemiale V, Mourvillier B, Kouatchet A, et al. Functional outcome after convulsive status epilepticus. Crit Care Med [Internet]. 2010;38(12):2295– 303. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20890201
dc.sourceDonaire A, Carreno M, Gómez B, Fossas P, Bargalló N, Agudo R, et al. Cortical laminar necrosis related to prolonged focal status epilepticus. J Neurol Neurosurg Psychiatry [Internet]. 2006;77(1):104–6. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2117425&tool=pmcentrez&re ndertype=abstract
dc.sourceHesdorffer DC, Logroscino G, Cascino GD, Hauser WA. Recurrence of afebrile status epilepticus in a population-based study in Rochester, Minnesota. Neurology. 2007;69(1):73– 8
dc.sourceFisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia. 2014
dc.sourceAdachi N, Kanemoto K, Muramatsu R, Kato M, Akanuma N, Ito M, et al. Intellectual prognosis of status epilepticus in adult epilepsy patients: Analysis with Wechsler Adult Intelligence Scale-Revised. Epilepsia. 2005;46(9):1502–9
dc.sourceMutis JA, Rodríguez JH, Nava-Mesa MO. Rapidly progressive cognitive impairment with neuropsychiatric symptoms as the initial manifestation of status epilepticus. Epilepsy Behav Case Reports [Internet]. 2017;7:20–3. Available from: http://linkinghub.elsevier.com/retrieve/pii/S221332321630055X
dc.sourceAukland P, Lando M, Vilholm O, Christiansen EB, Beier CP. Predictive value of the Status Epilepticus Severity Score (STESS) and its components for long-term survival. BMC Neurol [Internet]. 2016;16(1):213. Available from: http://bmcneurol.biomedcentral.com/articles/10.1186/s12883-016-0730-0
dc.sourceSantamarina E, González-Cuevas GM, Sanchez A, Gracia RM, Porta I, Toledo M, et al. Prognosis of status epilepticus in patients requiring intravenous anesthetic drugs (a single center experience). Seizure [Internet]. 2016; Available from: http://www.sciencedirect.com/science/article/pii/S1059131116303028
dc.sourceGiovannini G, Monti G, Tondelli M, Marudi A, Valzania F, Leitinger M, et al. Mortality, morbidity and refractoriness prediction in status epilepticus: Comparison of STESS and EMSE scores. Seizure [Internet]. 2017;46:31–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1059131116302102
dc.sourcePalau Pérez M, Vélez Van Meerbeke A, Gutiérrez Álvarez A, Quintero P, Ortiz Salas P SF. Caracterización de pacientes adultos mayores con epilepsia en dos hospitales en Bogotá, Colombia. Bogotá: Revista de Ciencias de la Salud; 2010. 1-41 p
dc.sourceMartinez A, Velandia A, Ortega M, Peña I, Pradilla O, Gómez R. Estatus epiléptico en FOSCAL, 2014-2015: Caracterización epidemiológica. Revista Acta Neurológica Colombiana. 2016; 32 (1 Supl 1). 17-18 p
dc.sourceNasreddine W, Beydoun A. Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia. 2008 Mar;49(3):438-45
dc.sourceChoi YF, Wong TW, Lau CC. Midazolam is more likely to cause hypotension than etomidate in emergency department rapid sequence intubation. Emerg Med J. 2004 Nov;21(6):700-2
dc.sourceFernández A, Lantigua H, Lesch C et col. High-dose midazolam infusion for refractory status epilepticus. Neurology. 2014 Jan 28; 82(4): 359–365
dc.sourceKang Su B, Wook Kim D, Ki Kim K et col. Prediction of mortality and functional outcome from status epilepticus and independent external validation of STESS and EMSE scores. Crit Care. 2016; 20: 25
dc.sourceSutter R, Kaplan PW, Ruegg S. Independent external validation of the status epilepticus severity score. Crit Care Med. 2013 Dec;41(12):e475-9
dc.sourceGao Q, Ou-Yang TP, Sun XL et col. Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score. Crit Care. 2016 Feb 25;20:46
dc.sourceWellmer J, Quesada CM, Rothe L, Elger CE, Bien CG, Urbach H. Proposal for a Magnetic Resonance Imaging Protocol for the Detection of Epileptogenic Lesions at Early Outpatient Stages. Epilepsia. 2013;54:1977–1987
dc.sourceHirsch LJ, Laroche SM, Gaspard N et col. American Clinical Neurophysiology Society’s Standardized Critical Care EEG Terminology: 2012 version. J Clin Neurophysiol 2013;30: 1– 27)
dc.sourceHawkes M, Hocker S. Systemic Complications Following Status Epilepticus. Current Neurology and Neuroscience Reports (2018) 18:7
dc.sourceTiamkao S, Saybungkla P, Sirikarn P et col. Predictors of long-term mortality in status epilepticus. Epilepsy & Behavior. 84 (2018) 114–117
dc.sourceTrinka E, Leitinger M. Which EEG patterns in coma are nonconvulsive status epilepticus? Epilepsy & Behavior. 49 (2015) 203–222
dc.sourceAtmaca MM, Bebek N, Baykan B. Predictors of outcomes and refractoriness in status epilepticus: A prospective study. Epilepsy & Behavior. 75 (2017) 158–164
dc.sourceZhang Yu, Cheng D, Xu Dm Tan G, Lui L. Clinical utility of EMSE and STESS in predicting hospital mortality for status epilepticus. Seizure 60 (2018) 23–28
dc.sourceSilbergleit R, Lowenstein D, Durlaski V. RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): A double-blind randomized clinical trial of the efficacy of IM midazolam versus IV lorazepam in the pre-hospital treatment of status epilepticus by paramedics. Epilepsia. 2011 Oct; 52(Suppl 8): 45–47
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectEstado epiléptico
dc.subjectElectroencefalografía (EEG)
dc.subjectmortalidad
dc.subjectpronóstico
dc.subjectExamen diagnostico de la epilepsia
dc.subjectEEG
dc.subjectEstado epiléptico convulsivo (CSE)
dc.subjectepilepsia
dc.subjectEstado epiléptico no convulsivo (NCSE)
dc.subjectEscala STESS
dc.subjectestado epiléptico convulsivo (CSE)
dc.subjectestado epiléptico no convulsivo (NCSE)
dc.subjectescala STESS.
dc.titleCaracterización epidemiológica y factores relacionados con mal pronóstico en pacientes mayores de 18 años con estado epiléptico atendidos en el servicio de Neurología de la Fundación Cardioinfantil entre los años 2016 a 2018
dc.typemasterThesis


Este ítem pertenece a la siguiente institución